From: MedPage Today [mailto:[log in to unmask]] 
Sent: September 06, 2011 12:09
To: [log in to unmask]
Subject: Breaking News: FDA Reviewer Slams Xarelto for Stroke Prevention in Afib



Tuesday September 06, 2011
FDA Reviewer Slams Xarelto for Stroke Prevention in Afib 
WASHINGTON -- Rivaroxaban (Xarelto) is not as effective as warfarin for preventing strokes in patients with atrial fibrillation and should not be approved for the new indication, according to an FDA reviewer.
http://www.medpagetoday.com/Cardiology/Strokes/28367?utm_source=breaking-news&utm_medium=email&utm_campaign=breaking-news

You have received this email because you have registered to receive alert emails at
www.medpagetoday.com, with the email address: [log in to unmask]

Change ALL email settings

Instant Unsubscribe from "Breaking News Alerts"

TECHNICAL QUESTIONS:
[log in to unmask]
MedPage Today, LLC. - Overlook at Great Notch - 150 Clove Road - Little Falls, New Jersey 07424 - Tel: (973) 890-0985 - Fax: (973) 890-1327 

-----------------------

To change your mail settings or leave the C-PALSY list, go here:

http://listserv.icors.org/SCRIPTS/WA-ICORS.EXE?SUBED1=c-palsy